IONS IONIS PHARMACEUTICALS INC Contract Awards 8-K Filing 2023 - Collaboration Agreement with Novartis IONIS PHARMACEUTICALS INC entered into a collaboration and license agreement with Novartis Pharma AG to develop a medicine for patients with lipoprotein(a)-driven cardiovascular disease.Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC